These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 51958)

  • 1. Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity, and transmissibility.
    Morris CA; Freestone DS; Stealey VM; Oliver PR
    Lancet; 1975 Aug; 2(7927):196-9. PubMed ID: 51958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community.
    Morris CA; Freestone DS; Stealey VM
    Dev Biol Stand; 1976; 33():197-201. PubMed ID: 782969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules.
    Evans AE; Letley E; Ferris RD; Freestone DS
    J Hyg (Lond); 1976 Dec; 77(3):327-32. PubMed ID: 1069813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of live recombinant influenza vaccine.
    Stealey VM; McCahon D; Freestone DS
    Dev Biol Stand; 1976; 33():191-6. PubMed ID: 955267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WRL 105 strain (H3N2) live attenuated influenza vaccine: acceptability, reactivity, and antibody response in normal, bronchitic, and geriatric volunteers.
    Nicholson KG; Tyrrell DA; Freestone DS
    Lancet; 1976 Jun; 1(7973):1309-11. PubMed ID: 58306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    White WG; Freestone DS; Bowker CH; Barnes GM; Letley E; Ferris RD
    Dev Biol Stand; 1976; 33():202-6. PubMed ID: 782970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antibody responses and reactivity of "Alice" and WRL 105 strain live influenza vaccines.
    Morris CA; Stealey VM; Freestone DS; Porter DA
    Lancet; 1976 May; 1(7969):1118-20. PubMed ID: 57520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.
    Freestone DS; Bowker CH; Letley E; Ferris RD; White WG; Barnes GM
    J Hyg (Lond); 1976 Jun; 76(3):459-66. PubMed ID: 1064672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with live attenuated influenza vaccines.
    Douglas RG; Betts RF
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative trials of live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Mackenzie I; Lloyd J; Dent V
    J Hyg (Lond); 1975 Dec; 75(3):425-43. PubMed ID: 1059709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers.
    Evans AE; Simmons RL; Ferris RD; Hasell SK; Letley E; Freestone DS
    J Hyg (Lond); 1979 Jun; 82(3):489-95. PubMed ID: 448065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical trial with Alice/R-75 strain, live attenuated serum inhibitor-resistant intranasal bivalent influenza A/B vaccine.
    Spencer MJ; Cherry JD; Powell KR; Sumaya CV
    Med Microbiol Immunol; 1979 Mar; 167(1):1-9. PubMed ID: 375050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial with "R-75" strain live, attenuated, serum inhibitor-resistant intranasal influenza B vaccine.
    Spencer MJ; Cherry JD; Powell KR
    J Clin Microbiol; 1977 Jun; 5(6):584-7. PubMed ID: 328526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attenuated influenza virus vaccine: Reactogenicity, transmissibility, immunogenicity, and protective efficacy.
    Lauteria SF; Kantzler GB; High PC; Lee JD; Waldman RH
    J Infect Dis; 1974 Oct; 130(4):380-3. PubMed ID: 4475057
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies with a live influenza A vaccine in army personnel.
    Donaldson A; Winsor HJ; Bennett NM; Gust ID
    Pathology; 1977 Jan; 9(1):49-56. PubMed ID: 323793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.